Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
What are the trade-offs
Glucagon and GLP- 1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
To learn more, visit PrimeTherapeutics.com or follow Prime on LinkedIn
David Cutler, MD, a board-certified family medicine physician at Providence Saint Johns Health Center in Santa Monica, CA, who was not involved in this study, told MNT that the current economics of supply and demand for GLP-1 medications makes health disparities unavoidable
US$ 28.34
US$ 22.65
US$ 23.27
US$ 28.99
US$ 27.16
US$ 23.27
US$ 24.67
